baricitinibmethotrexateMTXrheumatoid arthritisRACOMBOMONO
…Background Janus kinase inhibitors (JAKi), like baricitinib, are used as monotherapy (MONO) and in combination with methotr…
18articles mentioning drugs
55drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: MTX ×
MTX
This drug is selected. Its supporting articles are shown below.
Articles mentioning MTX
18 articles · page 2 of 2prednisoneIVIgMTXHCQMMFcyclophosphamideJohns Hopkinslate skin fibrosisskin fibrosissystemic sclerosis (SSc)+1 more
…onths. Most common medication exposure (ever) were MMF (58.5%), prednisone (44.5%), HCQ (34.7%), MTX (29.5%), IVIg (13.6%), and cyclophosp…
mycophenolate mofetiltofacitinibtocilizumabrituximabmethotrexateupadacitinibMTXprednisoneMMFJanus kinase inhibitors+1 more
…citinib or upadacitinib), rituximab, tocilizumab, methotrexate, mycophenolate mofetil, or glucocorticoids (>=10 mg prednisone equivalent daily) for m…
bosentanmethotrexatemycophenolate mofetilMTXMMFsystemic sclerosis (SSc)digital ulcersImmunosuppressive therapyDigital ulcers (DUs)
…development of a new digital ulcer despite at least 24 weeks of bosentan therapy. We included patients who were receiving concurrent tre…
RituximabIvIgcyclosporinMTXMMFSystemic sclerosis (SSc)psoriatic arthritisSSc/RASSc/SSSSc/myositis+2 more
…esponse was achieved with oral corticosteroids, cyclosporin and Rituximab, almost no response was obtained with MMF and MTX.Owing to the …
rituximabhydroxychloroquineleflunomideMTXsulfasalazinetocilizumabmethylprednisoloneupadacitinibRhupus
… refractory to multiple therapies, highlighting the response to rituximab. Prior reports support the benefit of rituximab in SLE-associat…